Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review

Journal of Affective Disorders

Volumn 152-154, Issue 1, 2014, Pages 12-18

  Buoli, Massimiliano ^a   Serati, Marta ^a   Altamura, A Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antipsychotics; Bipolar Disorder; Combined treatment; Mood stabilizers

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; DIVALPROATE; FLUPENTIXOL; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; ZIPRASIDONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; THIAZOLE DERIVATIVE; TRANQUILIZER;

AKATHISIA; BIPOLAR DISORDER; BRAIN DISEASE; COMBINATION CHEMOTHERAPY; CONSTIPATION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; GALACTORRHEA; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPOKINESIA; HYPOTHYROIDISM; INSOMNIA; LONG TERM CARE; MONOTHERAPY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TREMOR; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; XEROSTOMIA; DRUG COMBINATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; HUMANS; LONG-TERM CARE; PIPERAZINES; QUINOLONES; RISPERIDONE; THIAZOLES; TREATMENT OUTCOME;

EID: 84889086290     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.08.024     Document Type: Review

References (66)

1. S. Ali, R.L. Pearlman, A. Upadhyay, and P. Patel Neuroleptic malignant syndrome with aripiprazole and lithium: a case report Journal of Clinical Psychopharmacology 26 2006 434 436
2. R. Ali, G. Singh, J.W. Iskandar, and K.Y. Kim A case of intention tremor induced by the combination of aripiprazole and lamotrigine Primary Care Companion for CNS Disorders 14 2012 p. 1
3. A.C. Altamura, M. Buoli, A. Albano, and B. Dell'Osso Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study International Clinical Psychopharmacology 25 2010 172 179
4. A.C. Altamura, E. Mundo, B. Dell'Osso, G. Tacchini, M. Buoli, and J.R. Calabrese Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study Journal of Affective Disorders 110 2008 135 141
5. F. Bellivier Cognitions and functioning in euthymic bipolar patients: screening and treatment] Encephale 38 2012 151 154
6. N. Berry, S. Pradhan, R. Sagar, and S.K. Gupta Neuroleptic malignant syndrome in an adolescent receiving olanzapine -lithium combination therapy Pharmacotherapy 23 2003 255 259
7. J. Berwaerts, R. Melkote, I. Nuamah, and P. Lim A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode Journal of Affective Disorders 138 2012 247 258
8. H. Böker, M. Brandenberger, and C. Schopper Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder Psychiatrische Praxis 34 2007 38 41
9. K. Boora, J. Xu, and J. Hyatt Encephalopathy with combined lithium-risperidone administration Acta Psychiatrica Scandinavica 117 2008 394 395
10. M. Bourin, O. Lambert, and B. Guitton Treatment of acute mania - from clinical trials to recommendations for clinical practice Human Psychopharmacology 20 2005 15 26
11. M. Bourin, and F. Thibaut How assess drugs in the treatment of acute bipolar mania? Frontiers in Pharmacology 4 2013 1 11
12. C.L. Bowden, E. Vieta, K.S. Ice, J.H. Schwartz, P.P. Wang, and M. Versavel Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial Journal of Clinical Psychiatry 71 2010 130 137
13. C.L. Bowden, O.N. Karayal, J.H. Schwartz, B.K. Gundapaneni, and C. O'Gorman Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications Journal of Affective Disorders 144 2013 171 175
14. B.X. Carlson, T.A. Ketter, W. Sun, K. Timko, R.D. McQuade, R. Sanchez, E. Vester-Blokland, and R. Marcus Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392) Bipolar Disorders 14 2012 41 53
15. H.Y. Chan, S.H. Jou, Y.Y. Juang, C.J. Chang, J.J. Chen, C.H. Chen, and N.Y. Chiu A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania Psychiatry and Clinical Neurosciences 64 2010 162 169
16. J. Esparon, J. Kolloori, G.J. Naylor, A.M. McHarg, A.H. Smith, and S.E. Hopwood Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients British Journal of Psychiatry 148 1986 723 725
17. K.R. Estabrook, and M. Pheister A case of quetiapine XR and divalproex-associated neutropenia follone by successful use of ziprasidone Journal of Clinical Psychopharmacology 32 2012 417 418
18. K.N. Fountoulakis, S. Kasper, O. Andreassen, P. Blier, A. Okasha, E. Severus, M. Versiani, R. Tandon, H.J. Möller, and E. Vieta Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry European Archives of Psychiatry and Clinical Neurosciences 262 2012 1 48
19. P.E. Garfinkel, H.C. Stancer, and E. Persad A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania Journal of Affective Disorders 2 1980 279 288
20. J.R. Geddes, S. Burgess, K. Hawton, K. Jamison, and G.M. Goodwin Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials American Journal of Psychiatry 161 2004 217 222
21. S.A. Goldman Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae? Journal of Clinical Psychiatry 36 1996 951 962
22. R.D. Goldney, and N.D. Spence Safety of the combination of lithium and neuroleptic drugs American Journal of Psychiatry 143 1986 882 884
23. M.C. Hardoy, A. Garofalo, G. Mellino, F. Tuligi, M. Cadeddu, and M.G. Carta Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes Clinical Practice and Epidemiology in Mental Health 3 2007 1 4
24. G.G. Homish, D. Marshall, S.L. Dubovsky, and K. Leonard Predictors of later bipolar disorder in patients with subthreshold symptoms Journal of Affective Disorders 144 2013 129 133
25. J.P. Houston, M. Tohen, E.K. Degenhardt, H.H. Jamal, L.L. Liu, and T.A. Ketter Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study Journal of Clinical Psychiatry 70 2009 1540 1547
26. P.E. Keck Jr.; J.R. Calabrese, R.D. McQuade, W.H. Carson, B.X. Carlson, L.M. Rollin, R.N. Marcus, R. Sanchez Aripiprazole Study Group A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder Journal of Clinical Psychiatry 67 2006 626 637
27. L.L. Judd, and H.S. Akiskal The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases Journal of Affective Disorders 73 2003 123 131
28. A.F. Lehman, and D.M. Steinwachs Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations Schizophrenia Bulletin 24 1998 1 10
29. R.H. Lenox, P.A. Newhouse, W.L. Creelman, and T.M. Whitaker Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study Journal of Clinical Psychiatry 53 1992 47 52
30. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration British Medical Journal 21 2009 339, b2700
31. R.W. Licht Lithium: still a major option in the management of bipolar disorder CNS Neuroscience and Therapeutics 18 2012 219 226
32. M.R. Lowe, and D.H. Batchelor Depot neuroleptics and manic depressive psychosis International Clinical Psychopharmacology 1 1986 53 62
33. W. Macfadden, L. Alphs, J.T. Haskins, N. Turner, I. Turkoz, C. Bossie, M. Kujawa, and R. Mahmoud A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently Bipolar Disorders 11 2009 827 839
34. W. Macfadden, C.M. Adler, I. Turkoz, J.T. Haskins, N. Turner, and L. Alphs Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms BMC Psychiatry 11 2011 171
35. G.S. Malhi, M. Tanious, P. Das, and M. Berk The science and practice of lithium therapy Australian and New Zealand Journal of Psychiatry 46 2012 192 211
36. S.C. Mann, R.A. Greenstein, and R. Eilers Early onset of severe dyskinesia following lithium-haloperidol treatment American Journal of Psychiatry 140 1983 1385 1386
37. R. Marcus, A. Khan, L. Rollin, B. Morris, K. Timko, W. Carson, and R. Sanchez Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study Bipolar Disorders 13 2011 133 144
38. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement British Medical Journal 339 2009 b2535
39. E. Mora, M.J. Portella, I. Forcada, E. Vieta, and M. Mur Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study Psychological Medicine 31 2012 1 10
40. W.C. Ouyang, M.C. Hsu, I.N. Yeh, and C.C. Kuo Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania International Journal of Psychiatry in Clinical Practice 16 2012 178 188
41. M.N. Pavuluri, D.B. Henry, J.A. Carbray, G. Sampson, M.W. Naylor, and P.G. Janicak Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania Journal of Affective Disorders 82 2004 103 111
42. M.V. Peitl, V. Peitl, T. Grahovac, and E. Pavlović Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder Psychiatria Danubina 22 2010 125 127
43. S. Pini, V. de Queiroz, D. Pagnin, L. Pezawas, J. Angst, G.B. Cassano, and H.U. Wittchen Prevalence and burden of bipolar disorders in European countries European Neuropsychopharmacology 15 2005 425 434
44. J.A. Quiroz, L.N. Yatham, J.M. Palumbo, K. Karcher, S. Kushner, and V. Kusumakar Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder Biological Psychiatry 68 2010 156 162
45. J. Scott, and F. Colom Psychosocial treatments for bipolar disorders Psychiatric Clinics of North America 28 2005 371 384
46. Y.C. Shen, S.J. Chen, C.C. Lin, and C.H. Chen Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome? International Clinical Psychopharmacology 22 2007 247 248
47. J.G. Small, M.H. Klapper, J.D. Marhenke, V. Milstein, G.C. Woodham, and J.J. Kellams Lithium combined with carbamazepine or haloperidol in the treatment of mania Psychopharmacol Bulletin 31 1995 265 272
48. K.N. Sokolski, and T.F. Denson Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate Progress in Neuro- Psychopharmacology and Biological Psychiatry 27 2003 863 866
49. G. Spring, and M. Frankel New data on lithium and haloperidol incompatibility American Journal of Psychiatry 138 1981 818 821
50. S.M. Strakowski, M.P. DelBello, M.E. Zimmerman, G.E. Getz, N.P. Mills, J. Ret, P. Shear, and C.M. Adler Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder American Journal of Psychiatry 159 2002 1841 1847
51. T. Suppes, E. Vieta, S. Liu, M. Brecher, B. Paulsson Trial 127 Investigators Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127) American Journal of Psychiatry 166 2009 476 488
52. M. Tohen, K.N. Chengappa, T. Suppes, R.W. Baker, C.A. Zarate, C.L. Bowden, G.S. Sachs, D.J. Kupfer, S.N. Ghaemi, P.D. Feldman, R.C. Risser, A.R. Evans, and J.R. Calabrese Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone British Journal of Psychiatry 184 2004 337 345
53. M. Tohen, W. Greil, J.R. Calabrese, G.S. Sachs, L.N. Yatham, B.M. Oerlinghausen, A. Koukopoulos, G.B. Cassano, H. Grunze, R.W. Licht, L. Dell'Osso, A.R. Evans, R. Risser, R.W. Baker, H. Crane, M.R. Dossenbach, and C.L. Bowden Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial American Journal of Psychiatry 162 2005 1281 1290
54. M. Tohen, C.L. Bowden, A.B. Smulevich, R. Bergstrom, T. Quinlan, O. Osuntokun, W.V. Wang, H.S. Oliff, F. Martenyi, L.A. Kryzhanovskaya, and W. Greil Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes British Journal of Psychiatry 192 2008 135 143
55. E. Vieta, M. Reinares, B. Corbella, A. Benabarre, I. Gilaberte, F. Colom, A. Martínez-Arán, C. Gastó, and M. Tohen Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder Journal of Clinical Psychopharmacology 21 2001 469 473
56. E. Vieta, J.M. Goikolea, J.M. Olivares, A. González-Pinto, A. Rodriguez, F. Colom, M. Comes, C. Torrent, and J. Sánchez-Moreno 1-year follow-up of patients treated with risperidone and topiramate for a manic episode Journal of Clinical Psychiatry 64 2003 834 839
57. E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson, and M. Brecher Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126) Journal of Affective Disorders 109 2008 251 263
58. E. Vieta, C. T'joen, R.D. McQuade, W.H. Carson Jr.; R.N. Marcus, R. Sanchez, R. Owen, and L. Nameche Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study American Journal of Psychiatry 165 2008 1316 1325
59. E. Vieta, R. Owen, C. Baudelet, R.D. McQuade, R. Sanchez, and R.N. Marcus Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study Current Medical Research and Opinion 26 2010 1485 1496
60. E. Vieta, S. Montgomery, A.H. Sulaiman, R. Cordoba, B. Huberlant, L. Martinez, and A. Schreiner A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder European Neuropsychopharmacology 22 2012 825 835
61. E. Vieta, T. Suppes, B. Ekholm, M. Udd, and U. Gustaffson Long-term efficacy of quetiapine on combination with lithium/divalproex on mixed symptoms in bipolar I disorder Journal of Affective Disorders 142 2012 36 44
62. R.H. Weisler, W.A. Nolen, A. Neijber, A. Hellqvist, B. Paulsson Trial 144 Study Investigators. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: a randomized controlled study) Journal of Clinical Psychiatry 72 2011 1452 1464
63. L.N. Yatham, C. Binder, V. Kusumakar, and R. Riccardelli Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania International Clinical Psychopharmacology 19 2004 103 109
64. L.N. Yatham, E. Vieta, A.H. Young, H.J. Möller, B. Paulsson, and M. Vågerö A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania International Clinical Psychopharmacology 22 2007 212 220
65. Yatham, L.N.; Fountoulakis, K.N.; Rahman, Z.; Ammerman, D.; Fyans, P.; Marler, S.V.; Baker, R.A.; Carlson, B.X.; 2013. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. Journal of Affective Disorders 147, 365-372
66. R. Yoshimura, N. Ueda, K. Shinkai, and J. Nakamura Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium Pharmacopsychiatry 39 2006 233 234